Proteoglycans in the control of tumor growth and metastasis formation

Sabrina Cattaruzza, Pier Andrea Nicolosi, Roberto Perris

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Proteoglycans (PGs) as a whole, or when considering their GAG chains as single entities, are emerging as key regulators of tumor progression. Expectations on using them as putative prognostic markers and potential therapeutic targets are increasing coincidentally. Due to the multitude of biological roles that they may invest and the ample spectrum of cellular processes that they may control, we still need to learn better how they regulate phenomena such as intracellular signaling, proliferation, apoptosis, motility, and drug resistance. Depending on the type, their expression pattern, and the accessibility of their molecular ligands, PGs can either promote or inhibit tumorigenesis. The structural and functional diversity of PGs coupled with their ubiquitous abundance place them at the crossroads of many critical steps within the metastatic cascade. As this phenomenon is the pivotal factor for patient survivals, particular attention should be given to the understanding of how PGs govern metastasis formation.

Original languageEnglish
Pages (from-to)225-229
Number of pages5
JournalConnective Tissue Research
Volume49
Issue number3-4
DOIs
Publication statusPublished - May 2008

Fingerprint

Proteoglycans
Tumors
Neoplasm Metastasis
Growth
Neoplasms
Drug Resistance
Carcinogenesis
Apoptosis
Ligands
Survival
Pharmaceutical Preparations
Therapeutics

Keywords

  • Metastasis
  • NG2
  • Proteoglycans
  • Tumor

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Nephrology
  • Cell Biology
  • Orthopedics and Sports Medicine

Cite this

Proteoglycans in the control of tumor growth and metastasis formation. / Cattaruzza, Sabrina; Nicolosi, Pier Andrea; Perris, Roberto.

In: Connective Tissue Research, Vol. 49, No. 3-4, 05.2008, p. 225-229.

Research output: Contribution to journalArticle

Cattaruzza, Sabrina ; Nicolosi, Pier Andrea ; Perris, Roberto. / Proteoglycans in the control of tumor growth and metastasis formation. In: Connective Tissue Research. 2008 ; Vol. 49, No. 3-4. pp. 225-229.
@article{bb124d09a57746e09de69079ee2cf833,
title = "Proteoglycans in the control of tumor growth and metastasis formation",
abstract = "Proteoglycans (PGs) as a whole, or when considering their GAG chains as single entities, are emerging as key regulators of tumor progression. Expectations on using them as putative prognostic markers and potential therapeutic targets are increasing coincidentally. Due to the multitude of biological roles that they may invest and the ample spectrum of cellular processes that they may control, we still need to learn better how they regulate phenomena such as intracellular signaling, proliferation, apoptosis, motility, and drug resistance. Depending on the type, their expression pattern, and the accessibility of their molecular ligands, PGs can either promote or inhibit tumorigenesis. The structural and functional diversity of PGs coupled with their ubiquitous abundance place them at the crossroads of many critical steps within the metastatic cascade. As this phenomenon is the pivotal factor for patient survivals, particular attention should be given to the understanding of how PGs govern metastasis formation.",
keywords = "Metastasis, NG2, Proteoglycans, Tumor",
author = "Sabrina Cattaruzza and Nicolosi, {Pier Andrea} and Roberto Perris",
year = "2008",
month = "5",
doi = "10.1080/03008200802143448",
language = "English",
volume = "49",
pages = "225--229",
journal = "Connective Tissue Research",
issn = "0300-8207",
publisher = "Informa Healthcare",
number = "3-4",

}

TY - JOUR

T1 - Proteoglycans in the control of tumor growth and metastasis formation

AU - Cattaruzza, Sabrina

AU - Nicolosi, Pier Andrea

AU - Perris, Roberto

PY - 2008/5

Y1 - 2008/5

N2 - Proteoglycans (PGs) as a whole, or when considering their GAG chains as single entities, are emerging as key regulators of tumor progression. Expectations on using them as putative prognostic markers and potential therapeutic targets are increasing coincidentally. Due to the multitude of biological roles that they may invest and the ample spectrum of cellular processes that they may control, we still need to learn better how they regulate phenomena such as intracellular signaling, proliferation, apoptosis, motility, and drug resistance. Depending on the type, their expression pattern, and the accessibility of their molecular ligands, PGs can either promote or inhibit tumorigenesis. The structural and functional diversity of PGs coupled with their ubiquitous abundance place them at the crossroads of many critical steps within the metastatic cascade. As this phenomenon is the pivotal factor for patient survivals, particular attention should be given to the understanding of how PGs govern metastasis formation.

AB - Proteoglycans (PGs) as a whole, or when considering their GAG chains as single entities, are emerging as key regulators of tumor progression. Expectations on using them as putative prognostic markers and potential therapeutic targets are increasing coincidentally. Due to the multitude of biological roles that they may invest and the ample spectrum of cellular processes that they may control, we still need to learn better how they regulate phenomena such as intracellular signaling, proliferation, apoptosis, motility, and drug resistance. Depending on the type, their expression pattern, and the accessibility of their molecular ligands, PGs can either promote or inhibit tumorigenesis. The structural and functional diversity of PGs coupled with their ubiquitous abundance place them at the crossroads of many critical steps within the metastatic cascade. As this phenomenon is the pivotal factor for patient survivals, particular attention should be given to the understanding of how PGs govern metastasis formation.

KW - Metastasis

KW - NG2

KW - Proteoglycans

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=48549094284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48549094284&partnerID=8YFLogxK

U2 - 10.1080/03008200802143448

DO - 10.1080/03008200802143448

M3 - Article

C2 - 18661348

AN - SCOPUS:48549094284

VL - 49

SP - 225

EP - 229

JO - Connective Tissue Research

JF - Connective Tissue Research

SN - 0300-8207

IS - 3-4

ER -